SHREE GANESH REMEDIES
Back to Income Statement
|
SHREE GANESH REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Consolidated Net Profit | ₹28 Cr | ₹1,047,056 Cr | ₹6.24 Cr | ₹6.24 Cr |
What is the latest Consolidated Net Profit of SHREE GANESH REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹1,047,056 Cr |
| Mar2020 | ₹6.24 Cr |
| Mar2019 | ₹6.24 Cr |
How is Consolidated Net Profit of SHREE GANESH REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | -100.00 | |
| Mar2024 | ₹1,047,056 Cr | 16,793,096.95 | |
| Mar2020 | ₹6.24 Cr | 0.00 | |
| Mar2019 | ₹6.24 Cr | - | |
Compare Consolidated Net Profit of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹605.3 Cr | 0.7% | -4.4% | -31.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 0.7% |
-4.4% |
-31.5% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses